Skip to main content

J&J Beats On Q1 Earnings, Suspends COVID Jab Sales View

Johnson & Johnson’s first-quarter 2022 earnings came in at $2.67 per share.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.